Literature DB >> 8960437

Cardiovascular complications and anabolic steroids.

R D Dickerman, W J McConathy, F Schaller, N Y Zachariah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8960437     DOI： 10.1093/oxfordjournals.eurheartj.a014812

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

1.  Adverse effect of the anabolic-androgenic steroid mesterolone on cardiac remodelling and lipoprotein profile is attenuated by aerobicz exercise training.

Authors:  Karina Fontana; Helena Coutinho Franco Oliveira; Marta Beatriz Leonardo; Carlos Alberto Mandarim-de-Lacerda; Maria Alice da Cruz-Höfling
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

2.  Testosterone and cardiovascular disease in men.

Authors:  Paul D Morris; Kevin S Channer
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

Review 3.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 4.  Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.

Authors:  Paola Frati; Francesco P Busardò; Luigi Cipolloni; Enrico De Dominicis; Vittorio Fineschi
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

Review 5.  Endobiogeny: a global approach to systems biology (part 1 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat
Journal:  Glob Adv Health Med       Date:  2013-01

Review 6.  Endobiogeny: a global approach to systems biology (part 2 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat; Patrice Pauly
Journal:  Glob Adv Health Med       Date:  2013-03

Review 7.  Anabolic-androgenic steroids and cardiovascular risk.

Authors:  Jian-Di Liu; Yan-Qing Wu
Journal:  Chin Med J (Engl)       Date:  2019-09-20       Impact factor: 2.628
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.